Skip to main content

Article

Let’s Talk: The latest takes in the life sciences industry

Thought-provoking insights and discussions capture what’s on the minds of innovative life sciences leaders.

Learn how biopharma leaders tackle their big challenges

Join Optum Life Sciences leaders as they facilitate meaningful discussions on topics, including real-world data, precision medicine and more. Through these conversations, we identify actionable insights that tackle some of our toughest challenges in the industry to help improve patients' lives.

Our conversations

Let’s Talk: Interview #1

Value assessment

Learn how the Innovation and Value Initiative helps to advance the science, practice and use of health technology assessment in health care.

Let’s Talk: Interview #2

Real-world data and precision medicine

Chris Boone weighs in on what's needed to propel personalized disease prevention and treatment efforts forward.

Let’s Talk: Interview #3

Health equity and clinical trials

Shalini Mohan and Jamie Freedman share how their work challenged clinical development myths and supported underserved communities.

Related healthcare insights

View all

Article

How real-world evidence can inform pharma strategies in 2025

Health economics and outcomes research (HEOR) can play a key role in helping the life sciences industry improve patient outcomes.

Article

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.

On-demand webinar

How to maximize ROI real world data

Optum experts give a snapshot of commonly encountered pitfalls when using RWD and recommendations to help avoid them in this PMSA webinar.